ML18071A413

Advisory Committee on the Medical Uses of Isotopes (ACMUI) Physical Presence Requirements for the Leksell Gamma Knife Icon, Final Report, February 27, 2018

ML18071A413
Person / Time
Issue date:	02/27/2018
From:	Sophie Holiday Advisory Committee on the Medical Uses of Isotopes, Office of Nuclear Material Safety and Safeguards
To:
Holiday, Sophie
References
Download: ML18071A413 (7)

Text

1 of 7 Nuclear Regulatory Commission (NRC) Advisory Committee on the Medic al Use of Isotopes (ACMUI)

Subcommittee on Physical Presence Requirements for the Leksell Gamma Knife IconŽ Final Report Submitted On:

February 27, 2018 Subcommittee Members:

Ronald Ennis, M.D. John Suh, M.D. (Chair)

Laura Weil NRC Staff Resource: Sophie Holiday

Charge to subcommittee: To propose the appropriate physical presence requirement for the Leksell Gamma Knife IconŽ radiosurgery unit.

Subcommittee Process

The subcommittee and its Chair were appointed by ACMUI Chairman, Phil Alderson, at the regularly scheduled ACMUI meeting April 26, 2017. This subcommittee was formed after a

presentation on April 26, 2017 by Elekta, Inc. requesting emendation of the Title 10 Code of Federal Regulations (10 CF R) 35.1000 licensing guidance for the Leksell Gamma Knife IconŽ to allow the authorized user (AU) to be physic ally present in the de partment during patient treatment and immediately available to come to the treatment room to respond to an emergency based on the very small number of medical ev ents (MEs) that have occurred with modern Gamma Knife units. The initial report was presented on September 12, 2017 at the ACMUI meeting. This is an updated report based on feedback from the last ACMUI meeting in September 2017.

Summary of Subcommittee Recommendations (for IconŽ unit in either the stereotactic frame or frameless mask mode)

• The AU and authorized medical physicist (AMP) need to be physically present during the initiation of all treatments. This allows independent confirmation that the correct plan is being used for treatment and that the correct site is being treated during the initiation of treatment.

• The current physical presence requirements for the AU be modified by allowing the AU to be present in the department during treatment, which is defined for the IconŽ as within a two minute walk to the console area, and immediately available to come to the treatment room. An AMP needs to be physica lly present during the entire treatment.

2 of 7 While we recognize the NRC does not have regulations for nurs ing or auxiliary staff, we recommend as a best practice that appropriate ly trained nursing or auxiliary staff be present at Gamma Knife treatment to respond to any immediate medical needs. It should be the responsibility of the AU to determine the necessary tr aining and experience required of the nursing staff.

• If there is an interruption of treatment secondary to medical or mechanical issues, the AU must return to Gamma Knife IconŽ console to evaluate the patient and/or to review any mechanical issues. The AU must be present to ensure the correct site is being treated prior to re-initiation of treatment.

• At the conclusion of treatment, the AU must be present at the IconŽ console to discuss and review any treatment or patient issues with the patien t, physicist, and nurse.

Introduction Gamma stereotactic radiosurgery is a very effective and well established treatment for patients with various benign and malignant brain tumors, vascular malformations and some functional disorders such as trigeminal neuralgia. The sh ielded unit utilizes 192 or 201 Cobalt-60 (Co-60) sources that simultaneously converg e to a central target in the br ain by the use of different sized collimator channels that are positioned around the patient's skull. The first Gamma Knife in the United States was installed at the University of Pittsburgh in 1987 (Model U). Over the next 12 years, the model B and model C units were introduced. These three systems, licensed under 10 CFR 35.600, (Models U, B and C) have tungsten collimators that are external to the Co-60 sources and are placed on the treatment unit manually. All these units required frame-based immobilization and have fixed beam geometry to maximize reliability and minimize quality assurance checks.

In 2006, the Perfexion

Ž unit was introduced. Unlike the model U, B, and C units, the collimators are inside the treatment unit with sources that can be shielded while the treatment helmet is being switched to another size collimator, which can decrease treatment times and manual intervention by the treatment team.

The Perfexion

Ž also uses five different positions (16 mm, 4 mm, off, 8 mm, and home, wh ich is an off position) to turn the beam on and off. These sectors allow for rapid change (within 1 second) of the collimators of each sector. Along with engineering differences that would not meet the provisions under 10 CFR 35.600, the NRC decided to license the Perfexion

Ž under 10 CFR 35.1000. In 2016, the Icon

Ž system was introduced, which allowed for treatment with a thermoplastic frameless mask unlike the PerfexionŽ unit. In addition, the Icon

Ž unit has a cone-beam computed tomography (CT) which provides stereotactic reference for patient se tup and high definition motion management for mask-based treatments. Since the introduction of the Gamma Knife in 1987 in the United States, the use of gamma stereota ctic radiosurgery has greatly increased in the United States. Based on information from Elekta, there are 77 Perfexion

Ž units and 22 Icon

Ž units. Worldwide, over 1 million patients have been treated with the Gamma Knife

.

Given the many advances in gamma stereotactic radiosurgery, the delivery has become more efficient allowing for treatment of multiple patients each day and treatment of multiple targets in 3 of 7 a single session, which have increased the treatment times for some patients. Given the evolution of the Gamma Knife over the past decade from the Model C to Perfexion

Ž and now IconŽ, the physical presence requirements were examined by the subcommittee.

Current Physical Presence Requirement In October 2002, the NRC modified the regulatio ns in 10 CFR Part 35 to include a section 1 regarding gamma stereotactic radiosurgery to include the requirement that "For gamma stereotactic radiosurgery unit require an Authorized User with appropriate training and experience in radiation oncology and Authorized Medical Physicist to be physically present throughout all patient treatments involving the unit." This regulati on provided for an appropriate response to an emergency and to ensure that th e correct dose of radiati on is delivered to the patient. The term 2 "physically present" was defined as "within hearing distance of normal voice".

The NRC issued a Regulatory Issue Summary (RIS) to clarify the definition of "physically present" as a result of an event at one of the Gamma Knife centers. The RIS (RIS-2005-23) 3 , "Clarification of the Physical Presence Requirement During Gamma Stereotactic Radiosurgery Treatment," stated that this meant speaking in a normal conversational tone and not a raised voice. As a result, a distance of 20 feet may not be close enough to adeq uately hear and respond to an emergent situation. This also ensu res the correct dose of radiation was delivered.

Rationale for change The current definition ensures that an emergent situation will be addressed immediately by the AU and that the correct dose is delivered. The AU has the knowledge and appropriate training to ensure the safe and effective delivery of stereota ctic radiosurgery. The current physical presence definition is not ambiguous and ensures the AU is pr esent for the all the critical portions of the procedure, able to address any medical issues that may arise during trea tment, and verify the correct dose will be delivered to the target(s). The AU will have the competency to recognize and respond to any aberration of treatment and ensure response times within seconds if needed.

Medical issues during the Gamma Knife treatment may include pain from the frame, nausea, vomiting, and seizure. Incorrect dose of radiation may result secondary to system failure which could be software, hardware, or combination of both. As serious medical issues and/or significant aberrations in treatment can result in reporta ble MEs, rules regulating physician presence exist to ensure patient safety.

Over the past ten years of NMED, there are 12 reportable events involving the Perfexion

Ž. Of the 12 Perfexion

Ž reportable events, only a minority were identified during treatment. The Icon unit has significant enhancements over the Perfexion

Ž unit. Specifically, three features are important: 1) the option of treatment with a thermoplastic frameless mask rather than a frame, 2) ability to perform integrated stereotactic cone-beam computed tomography (CT) which provides stereotactic reference for patient setup, and 3) high definition motion management for mask-based treatments. These enhancements re-ope n the question regardi ng the physical presence requirements of the AU for the entire treatment.

A review of the 12 events for Perfexion

Ž 4 of 7 reveals that none of these events would have escaped detection on an Icon unit using the thermoplastic frameless mask and high definition motion management for mask-based treatments

even if the AU was not physically at the consol e and could have been rapidly and effectively addressed as long as the AU was immediately available.

Proposal by Elekta, Inc. on April 26, 2017 for Gamma Knife IconŽ 1. We will have an Authorized User and Authorized Medical Physicist physically present during the initiation of all treatments involving the unit.

2. We will have an Authorized Medical Physicist physically present throughout all patient treatments involving the unit.

3. We will have an Authorized User physically present in the department during patient treatment and immediately available to come to the treatment room to respond to an emergency.

Recommendations Based on the extremely low number of MEs with the Perfexion

Ž unit coupled with the modifications with the Icon

Ž, the subcommittee recommends m odifying the current physical presence requirements for the Icon

Ž unit. The major differences between the Icon

Ž versus the PerfexionŽ are: 1) treatment with a thermoplastic frameless mask rather than invasive frame for some patients; 2) ability to perform integrated stereotactic cone-beam computed tomography (CT) which provides stereotactic reference fo r patient setup; and 3) high definition motion management for mask-based treatments whic h allows for online ad aptation. Although we respect the proposal by Elekta, Inc., we believe their proposal needs to be more stringent to ensure safe and accurate delivery of gamma stereotactic radiosurgery. Physical presence would utilize a similar definition used by Section V, Summary of changes of the 2002 revised 10 CFR part 35 in the Federal Register

4. The following recommendations remain consistent with federal regulations and requirements governing physician supervision from the Centers for Medicare and Medicaid Services and federal regulations. These recommendations are for either the stereotactic frame or frameless mask mode of the Icon

Ž. 1. AU and AMP be physically present during the initiation of all treatments involving the IconŽ unit. This will allow independent confirmation that the correct plan is being used for treatment and that the correct site is being treated at the initiation of treatment. This will also allow the authorized user to be part of the un iversal timeout, which should help prevent the wrong plan from being delivered or the incorrect side from being treated initially.

5 of 7 2. AMP be physically present throughout all patient treatments involving the unit.

The physical presence of an AMP is essentia l for the safe and accu rate delivery of gamma stereotactic radiosurgery. The addition of a medical physicist would ensure that any software, hardware, or combination of software/hardware failure be recognized immediately and addressed promptly.

The current physical presence requirements for the AU can be modified by allowing the AU to be close enough to the console to respond quickly to any issue th at arises which is defined as within a two minut e walking distance to the Icon

Ž console area, and immediately available to come to the treatment room. An AMP needs to be physically present during the entire treatment.

In addition to the AU and AMP, as a matter of good practice, we recommend that appropriately trained nursing or auxi liary staff be present during Icon

Ž treatment to respond to any immediate medical needs. It will be the responsibility of the AU to determine the necessary training and experience required of the nursing staff, who will be present throughout the procedure.

3. If there is an interruption of treatment secondary to medical or mechanical issues, the AU must return to the Gamma Knife IconŽ console to evaluate the patient and/or to review any mechanical issues. The AU must be present to ensure that the correct site is being treated during re-initiation of treatment.

4. At the conclusion of treatment, the AU must be present at the Icon

Ž console to discuss any treatment or patient issues with the patient, physicist, and nurse. The AU will be physically present close to the console, which is defined in this report as within 2 minutes from the console area, during patient treatment and immediately available to furnish assistance and direction throughout the performance of the procedur

e. Specifying time rather than presence in the department mitigates any misinterpretation of the regulations which has

happened in the past

5. This definition would be more stringent than the American Society for Radiation Oncology white paper.

6 The subcommittee felt that a time, rather than di stance, ought to be used to define "physically present in the department." Depending on the configuration of the department, distance may not be easily measured, i.e., the department may be located on multiple floors, not necessarily in close proximity. In addition, the subcommittee believes that 'physically present' in the department can be ambiguous especially if the Gamma Knife center is distant from the radiation oncology department or if the Gamma Knife is not present within the radiation oncology department such as a neurosurgery department or free standing center. Since a medical physicist would be physically present for the duration of treatments, medical and software/hardware incidents could be addressed during the 2 mi nute interval before the AU would arrive.

6 of 7 Summary: The subcommittee recommends that for the Leksell Gamma Knife IconŽ (either stereotactic frame or frameless mask mode):

• The AU and AMP need to be physically presen t during the initiation of all treatments. This allows independent confirmation that the correct site is being treated, confirm that the correct plan is being used for treatment and particularly important for functional cases, all of which are components of the universal time outs. It also provides an opportunity to visualize the movement of the treatment table to the correct position via treatment room cameras.

• The current physical presence requirements for the AU be modified by allowing the AU to be within a 2 minute walki ng distance of the console area and immediately available to come to the treatment room after initiation of treatments. An AMP needs to be physically present by the console area during the entire treatment. (i.e., at the console or within normal hearing voice) of the AU.

• If there is an interruption of treatment secondary to medical or mechanical issues, the AU must return to the Gamma Knife IconŽ console to evaluate the patient and/or to review any mechanical issues. The AU must be present to ensure the correct site is being treated during re-initiation of treatment.

• At the conclusion of treatment, the AU must be present at the Gamma Knife IconŽ console to discuss any treatment or patient issues with the patien t, AMP and nurse.

We believe that the recommendations would allow for the safe and effective delivery of gamma stereotactic radiosurgery while allowing the AU more flexibility to be available for other medical issues, other than those requiring personal supe rvision, in a radiation oncology department if warranted. We also believe that the recommendations will allow the licensee to determine if an ME has occurred, would allow the regulator to inspect and re gulate a Gamma Knife center, would not unfavorably encroach on the practice of medicine, and are consis tent with regulations governing physician supervision. As a subcommitt ee, we believe it is in appropriate for the AU to be more than a 2 minute walking distance from the console under any circumstance as the AU needs to be immediately available and needs to ensure the correct radiation dose is delivered. In addition, we recommend that the AU work with their radiation safety officer to determine how long it will take for the AU to return to the Gamma Knife IconŽ console area from another location at which he/she wishes to work. The center will need to determine best method to contact the physician as paging a physician can take time. Since any change can be subject to interpretation, it is important that each Gamma Knife center determine what area would be within 2 minutes walking distance of the console. Ultimately, each AU will need to decide if he or she wishes to adopt the revi sed physical presence proposal or maintain the current physical presence rules, which is more stringent.

Given the proposed change, it is imperative that a culture of safety and quality with checks and balances at every level exists to ensure that the safest and most effective care is delivered to 7 of 7 patients while simultaneously prot ecting the public. Licensees are encouraged to continue to audit and monitor their programs and adopt best practices including a high reliability system approach 7 to mitigate MEs.

Respectfully submitted, February 27, 2018 Subcommittee on Physical Presence Re quirements for Leks ell Gamma Knife IconŽ, Advisory Committee on the Medical Uses of Isotopes (ACMUI), Nuclear Regulatory Commission (NRC)

References

1. 10 CFR 35.615(f)(3).

2.Section V, Summary of changes of 2002 revi sed part 35 in Federal Register (67 FR 20355)

3. NRC-issued Regulatory Issues Summary (RIS) 2005 October 2005

4. 42 C.F.R. § 410.32

5. Mastroianni A, McCaffrey JF. Target tumors, not yourself: A review of False Claims Act allegations against radiation oncologists.

Appl Radiat Oncol 4(2): 14-21, 2015

6. Solberg TD, Balter JM, Benedict SH, et al.

Quality and safety considerations in stereotactic radiosurgery a nd stereotactic body radiation therapy: Executive summary.

Pract Radiat Oncol 2:2-9, 2012.

7. Reason J. Human error: models and management. BMJ 32:768-770, 2000